Hanmi Pharmaceutical Earnings Beat Expectations – What Drives the Rally? Hanmi Pharmaceutical is rated Buy: revenue +29.3% YoY, gross margin 59.6%, net income +115.2% YoY, but operating profit -36.0% YoY and China receivables governance risk remain. Valuation below average target. 2026년 09월 21일 English
Hyundai Steel Stock Held: Earnings Deteriorate Near-Term Hyundai Steel is rated Hold as revenue rises 2.7% YoY but operating profit drops 43.3% and net income falls 75.2%, despite a credible US EAF low-carbon catalyst. 2026년 09월 07일 English
Samsung Electro-Mechanics Re-Rating on Faster Earnings – AI Cycle Outlook Samsung Electro-Mechanics rated Buy: AI supply tightness boosts margins, with net income up 86% YoY while stock trades below analyst targets. 2026년 08월 27일 English
Kakao Stock Buy on Weakness: Profit Jumps 66% YoY Kakao stock gets a Buy rating as operating profit jumps 66% YoY, revenue rises 11.1%, and valuation looks discounted, despite governance risks from Kakao Mobility’s US IPO. 2026년 08월 20일 English
HD Hyundai Heavy Industries Earnings Soar: Margin Momentum Ahead HD Hyundai Heavy Industries is rated Buy as earnings surge with net income up 172% YoY, despite a three day safety shutdown that may delay output; valuation still suggests upside. 2026년 07월 28일 English
Hanwha Aerospace Profit Soars 338% YoY – Key Drivers Hanwha Aerospace is rated Buy as profits surged +338% YoY and margins expanded, supported by S&P A- and a $500m overseas bond, offering upside despite defense delivery risks. 2026년 07월 22일 English
Kakao Stock Looks Cheap After Profit Jump: Key Risks Kakao is rated Buy as operating profit surged 66 percent YoY with revenue up 11 percent, offering rerating upside, but net income is flat and risks include labor strain and regulation. 2026년 07월 15일 English
Hyundai Steel Turns Profitable – PER Suggests Upside Hyundai Steel shows real turnaround momentum: gross profit and operating profit improved and analysts rate it Buy, but net income is still negative and labor legal headline risks could disrupt margins. 2026년 06월 12일 English
Samsung Electro-Mechanics Earnings Jump on AI Parts – Key Outlook Samsung Electro-Mechanics shows strong AI component earnings: revenue up 17.2% YoY, operating profit up 40.0%, net income up 86.3%, supported by MLCC and FC-BGA demand. 2026년 06월 02일 English
Samsung Biologics Shares Rally on Strong Growth: Key Insights Samsung Biologics stays a Buy: despite labor, legal, and quality recall risks, 2026.03 revenue rose 25.8% YoY and operating profit 35.0% YoY, supporting margin resilience and upside. 2026년 06월 02일 English
